Market Overview

Benzinga's Top Pre-Market Losers

Related PGNX
Morning Market Movers
Earnings Scheduled For November 7, 2014
Progenics to present Phase 2 data for prostate cancer therapy candidate on Thursday (Seeking Alpha)
Related SLXP
Here's Why CRT Capital Boosted Valeant Pharmaceuticals' Price Target
Valeant Pharmaceuticals Is Kicking Butt, Says Canaccord Genuity
Jazz Pharmaceuticals Tops Q4 Earnings And Tests Buy Point (Investor's Business Daily)

Progenics Pharmaceuticals (NASDAQ: PGNX) shares fell 47.22% to $5.70 in the pre-market trading. Salix Pharmaceuticals Ltd (NASDAQ: SLXP) and Progenics Pharmaceuticals received a Complete Response Letter from the US Food and Drug Administration (FDA) for a Supplemental New Drug Application (sNDA) for RELISTOR.

Salix Pharmaceuticals Ltd (NASDAQ: SLXP) dipped 15.42% to $44.99 in the pre-market session. Analysts at Susquehanna downgraded Salix from “positive” to “neutral.”

Green Mountain Coffee Roasters (NASDAQ: GMCR) moved down 1.88% to $17.70 in the pre-market session. Green Mountain Coffee Roasters shares have dropped 82.65% over the past 52 weeks, while the S&P 500 index has gained 7.25% in the same period.

Masco (NYSE: MAS) dipped 1.58% to $13.09 in the pre-market session. Masco is expected to report its Q2 earnings after the closing bell.

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets


Related Articles (GMCR + MAS)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→